You have 9 free searches left this month | for more free features.

hlx07

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HLX07, nsqNSCLC, High EGFR Expression Trial in Shanghai (HLX07+carboplatin+pemetrexed, HLX07+docetaxel, HLX07)

Not yet recruiting
  • HLX07, nsqNSCLC, High EGFR Expression
  • Shanghai, China
    Shanghai Chest Hospital
Jul 5, 2022

CRC Trial (HLX07, HLX10, mFOLFOX6)

Not yet recruiting
  • CRC
  • HLX07
  • +2 more
  • (no location specified)
May 1, 2022

Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ) Trial in Wuwei, Shanghai (HLX07+HLX10+oxaliplatin+capecitabine,

Recruiting
  • Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
  • Wuwei, Gansu, China
  • +1 more
Apr 25, 2022

Advanced Hepatocellular Carcinoma Trial (HLX07, HLX10, HLX04)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • HLX07
  • +3 more
  • (no location specified)
May 1, 2022

Nasopharyngeal Carcinoma by AJCC V8 Stage Trial in Guanzhou (HLX07, HLX10, )

Not yet recruiting
  • Nasopharyngeal Carcinoma by AJCC V8 Stage
  • HLX07
  • +3 more
  • Guanzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 23, 2022

Solid Tumor Trial in Shanghai (HLX07)

Not yet recruiting
  • Solid Tumor
  • HLX07
  • Shanghai, China
    Fudan University shanghai cancer center
May 3, 2022

Cutaneous Squamous Cell Carcinoma Trial in Guangzhou (HLX07)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • HLX07
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Jun 15, 2022

Small-cell Lung Cancer Trial in Changchun (HLX07, HLX10, carboplatin and etoposide)

Not yet recruiting
  • Small-cell Lung Cancer
  • HLX07
  • +2 more
  • Changchun, Jilin, China
    Jilin Cancer Hospital
May 3, 2022

ESCC or Esophageal Adenosquamous Carcinoma Trial in Guangzhou (HLX07+HLX10+ Cisplatin+5-FU, HLX07)

Recruiting
  • ESCC or Esophageal Adenosquamous Carcinoma
  • HLX07+HLX10+ Cisplatin+5-FU
  • HLX07
  • Beijing, Beijing, China
  • +16 more
Aug 25, 2022